PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684396
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1684396
Cardiac AI monitoring diagnostics Market size was valued at USD 1,298.43 Million in 2024, expanding to a CAGR of 25.99% from 2025 to 2032.
Cardiac AI monitoring diagnostics are specially designed objects that mimic human tissues and organs for testing, calibrating, and optimizing medical imaging systems such as X-ray, CT, MRI, ultrasound, and nuclear medicine devices. They are used for quality control, training, and research in medical imaging.
Cardiac AI monitoring diagnostics Market- Market Dynamics
The increasing prevalence of cardiovascular disorders and higher adoption of machine learning & AI tools is expected to propel market demand
The global market for Cardiac AI Monitoring Diagnostics is experiencing significant growth due to advancements in artificial intelligence (AI), increasing cardiovascular disease (CVD) prevalence, and the rising adoption of remote monitoring technologies. Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide. According to the World Health Organization (WHO), CVDs account for approximately 17.9 million deaths annually, representing 31% of all global deaths. Conditions such as coronary artery disease, heart failure, arrhythmia, and hypertension require continuous monitoring and early intervention, making AI-powered cardiac diagnostics an essential tool for healthcare providers.
The integration of AI and machine learning (ML) algorithms in cardiac diagnostics has transformed the way heart diseases are detected and managed. AI algorithms analyze ECG, echocardiograms, MRI scans, and real-time physiological data to detect abnormalities faster and with higher accuracy than traditional methods. AI enhances early detection of arrhythmia, heart failure, and myocardial infarctions, enabling quicker clinical decision-making. With the shift towards home-based and remote healthcare, AI-powered cardiac monitoring devices have gained widespread acceptance. Wearable devices, such as smartwatches and ECG patches, continuously track heart rate, detect irregular rhythms, and alert patients and doctors in real-time.
Cardiac AI monitoring diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 25.99% over the forecast period (2025-2032)
Based on Device Type segmentation, the ECG monitor segment was predicted to show maximum market share in the year 2024, due to advancement in medical imaging.
Based on Deployment segmentation, the on-premises segment was the leading Deployment segment in 2024, owing to rapid innovations in diagnostic devices and the rise in demand for wearables.
Based on End User segmentation, the hospital & clinics segment was the leading End User segment in 2024, owing to high demand for medical devices in hospital diagnostics.
On the basis of the region, North America was the leading revenue generator in 2024, owing to early tech adoption & investment by medical companies.
The Global Cardiac AI monitoring diagnostics Market is segmented on the basis of Device Type, Deployment, End User, and Region.
The market is divided into six categories based on Device Type: ECG monitor, defibrillator, pacemaker, smart wearable, cardiac resynchronization therapy, and others. The ECG monitor segment dominates the market. The growing prevalence of cardiovascular diseases and cardiac failure are proliferating segment growth.
The market is divided into four categories based on Deployment: cloud-based and on-premises. The on-premises segment is expected to hold the largest share due to the rising demand for smart wearables & advanced AI tools.
The market is divided into three categories based on End User: hospital & clinics, home care settings, and others. The hospital & clinics segment holds the highest share of the End User segment. The widespread adoption of advanced medical devices in hospitals for diagnostic needs is spurring segment growth.
Cardiac AI monitoring diagnostics Market- Geographical Insights
Across the globe, the Cardiac AI monitoring diagnostics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Cardiac AI monitoring diagnostics market. This dominance is attributed to a well-established healthcare infrastructure, rapid adoption of advanced technologies, and a high prevalence of CVDs. The Asia-Pacific region is expected to experience the fastest growth in the cardiac AI monitoring and diagnostics market. The rapid expansion is due to the increasing prevalence of heart diseases, high demand for early disease diagnosis, developing healthcare infrastructure across China, India, etc.
The Cardiac AI monitoring diagnostics market is formulated by intense competition among key players striving to innovate and expand their product offerings. These innovations reflect the dynamic nature of the market, with companies continually advancing AI applications to improve cardiac monitoring and diagnostics. In addition, market players are indulging competitive strategies and continuous technological advancements to develop new products. The introduction of innovative products underscores the industry's commitment to enhancing cardiovascular care through artificial intelligence.
In 2024, Neko Health launched the Neko Body Scan, a device offering full-body health assessments, including detailed cardiovascular measurements, processed by AI tool.
In 2023, Philips acquired Cardiologs, a France based medical company spcialized in cardiac diagnostics.